Pay in 4 interest-free payments of $12.00 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Sacubitril (AHU-377) is converted by enzymatic cleavage of the ethyl ester into the active neprilysin inhibiting metabolite LBQ657
Administration of SR9009 alters circadian behavior and the circadian pattern of core clock gene expression in the hypothalami of mice
Mechanistic studies revealed that NSC319726 restores WT structure and function to the p53R175 mutant
(2011) Nature
It is highly selective for G9a/GLP over several other protein lysine and arginine methyltransferases
PQR-309 - CAS# 1225037-39-7 0216 Sacubitril (AHU-377) is converted byPQR 309, CAS No. 1225037 39 7, is an orally bioavailable pan inhibitor of phosphoinositide 3 kinases (PI3K) and inhibitor of the mammalian target of rapamycin (mTOR), with potential antineoplastic activity. PI3K mTOR kinase inhibitor PQR 309 inhibits the PI3K kinase isoforms alpha, beta, gamma and delta and, to a lesser extent, mTOR kinase, which may result in tumor cell apoptosis and growth inhibition in cells overexpressing PI3K mTOR. Activation of
US$ 12.00
US$ 4500.00
US$ 3750.00
US$ 6900.00
US$ 6650.00
US$ 8999.50
US$ 3400.00
US$ 4100.00
US$ 4500.00
US$ 5500.00
US$ 8650.00